Technical Analysis for NEXI - NexImmune, Inc.

Grade Last Price % Change Price Change
F 10.67 -10.93% -1.31
NEXI closed down 10.93 percent on Friday, July 23, 2021, on approximately normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Down Down
Historical NEXI trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Expansion Breakdown Bearish Swing Setup 0.00%
New 52 Week Low Weakness 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish -10.93%
Wide Bands Range Expansion -10.93%
Oversold Stochastic Weakness -10.93%
Wide Bands Range Expansion -16.18%
Oversold Stochastic Weakness -16.18%
Older End-of-Day Signals for NEXI ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
No Alerts Yet. Alerts will only show here if at least one person is tracking alerts on this stock.
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation (AIM) technology. The company has two product candidates in human trials, including NEXI-001 in acute myeloid leukemia, or AML; and NEXI-002 in multiple myeloma, or MM. NexImmune, Inc. was founded in 2011 and is headquartered in Gaithersburg, Maryland.

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Cancer Clinical Medicine Immunotherapy Acute Myeloid Leukemia Immunotherapies Leukemia Multiple Myeloma Immune Mediated Diseases

Is NEXI a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 28.0
52 Week Low 10.65
Average Volume 28,553
200-Day Moving Average 0.00
50-Day Moving Average 16.24
20-Day Moving Average 13.87
10-Day Moving Average 12.50
Average True Range 1.05
ADX 41.96
+DI 9.44
-DI 32.05
Chandelier Exit (Long, 3 ATRs) 13.59
Chandelier Exit (Short, 3 ATRs) 13.81
Upper Bollinger Bands 17.12
Lower Bollinger Band 10.62
Percent B (%b) 0.01
BandWidth 46.83
MACD Line -1.37
MACD Signal Line -1.22
MACD Histogram -0.1467
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 13.47
Resistance 3 (R3) 13.77 13.14 13.00
Resistance 2 (R2) 13.14 12.43 12.99 12.85
Resistance 1 (R1) 11.91 11.99 11.59 11.60 12.69
Pivot Point 11.28 11.28 11.12 11.13 11.28
Support 1 (S1) 10.04 10.57 9.73 9.74 8.65
Support 2 (S2) 9.41 10.13 9.26 8.49
Support 3 (S3) 8.18 9.41 8.34
Support 4 (S4) 7.87